1-5 of 5
Herve Ghesquieres
Close
Sort by
Journal Articles

Challenges for quality and utilization of real-world data for diffuse large B-cell lymphoma in REALYSA, a LYSA cohort

Clinical Trials & Observations
Hervé Ghesquières, Fanny Cherblanc, Aurélien Belot, Sophie Micon, Krimo K. Bouabdallah, Cyril Esnault, Luc-Matthieu Fornecker, Katia Thokagevistk, Maxime Bonjour, Fontanet Bijou, Corinne Haioun, Nadine Morineau, Loïc Ysebaert, Gandhi Damaj, Benoit Tessoulin, Stéphanie Guidez, Franck Morschhauser, Catherine Thiéblemont, Adrien Chauchet, Rémy Gressin, Fabrice Jardin, Christophe Fruchart, Gaëlle Labouré, Ludovic Fouillet, Pauline Lionne-Huyghe, Antoine Bonnet, Laure Lebras, Sandy Amorim, Cécile Leyronnas, Gaelle Olivier, Romain Guieze, Roch Houot, Vincent Launay, Bernard Drénou, Olivier Fitoussi, Laurence Detourmignies, Julie Abraham, Carole Soussain, Florence Lachenal, Gian Matteo Pica, Patrick Fogarty, Pascale Cony-Makhoul, Adeline Bernier, Sandra Le Guyader-Peyrou, Alain Monnereau, Frédéric Boissard, Cédric Rossi, Vincent Camus
Journal: Blood Advances
Blood Adv (2024) 8 (2): 296–308.
https://doi.org/10.1182/bloodadvances.2023010798
Published: 2024
Includes: Supplemental data
Journal Articles

HLA-DR expression on monocytes and outcome of anti-CD19 CAR T-cell therapy for large B-cell lymphoma

Estelle Bourbon, Pierre Sesques, Morgane Gossez, Jérémie Tordo, Emmanuelle Ferrant, Violaine Safar, Florent Wallet, Guillaume Aussedat, Alizée Maarek, Fadhela Bouafia, Lionel Karlin, Dana Ghergus, Camille Golfier, Hélène Lequeu, Anne Lazareth, Vérane Schwiertz, Sébastien Viel, Maryam Idlhaj, Hervé Ghesquières, Guillaume Monneret, Emmanuel Bachy, Fabienne Venet
Journal: Blood Advances
Blood Adv (2023) 7 (5): 744–755.
https://doi.org/10.1182/bloodadvances.2021006563
Published: 2023
Includes: Supplemental data
Journal Articles

Outcomes of older patients with diffuse large B-cell lymphoma treated with R-CHOP: 10-year follow-up of the LNH03-6B trial

Vincent Camus, Aurélien Belot, Lucie Oberic, David Sibon, Hervé Ghesquières, Catherine Thieblemont, Christophe Fruchart, Olivier Casasnovas, Jean-Marie Michot, Thierry Jo Molina, André Bosly, Clémentine Joubert, Corinne Haioun, Emmanuelle Nicolas-Virelizier, Pierre Feugier, Olivier Fitoussi, Richard Delarue, Hervé Tilly
Journal: Blood Advances
Blood Adv (2022) 6 (24): 6169–6179.
https://doi.org/10.1182/bloodadvances.2022007609
Published: 2022
Includes: Supplemental data
Journal Articles

Clinicopathological features and survival in EBV-positive diffuse large B-cell lymphoma not otherwise specified

Clinical Trials & Observations
Estelle Bourbon, Delphine Maucort-Boulch, Juliette Fontaine, Claire Mauduit, Pierre Sesques, Violaine Safar, Emmanuelle Ferrant, Camille Golfier, Dana Ghergus, Lionel Karlin, Anne Lazareth, Fadhela Bouafia, Gian Matteo Pica, Frédérique Orsini-Piocelle, Clément Rocher, François-Xavier Gros, Marie Parrens, Arthur Dony, Cédric Rossi, Hervé Ghesquières, Emmanuel Bachy, Alexandra Traverse-Glehen, Clémentine Sarkozy
Journal: Blood Advances
Blood Adv (2021) 5 (16): 3227–3239.
https://doi.org/10.1182/bloodadvances.2021004515
Published: 2021
Includes: Supplemental data
Journal Articles

Incidence of central nervous system relapses in patients with DLBCL treated with lenalidomide as maintenance after R-CHOP

Clinical Trials & Observations
Sophie Bernard, Herve Ghesquieres, Rene-Olivier Casasnovas, Samuel Griolet, Maria Gomes da Silva, Pierre Feugier, Franck Morschhauser, Judith Trotman, Loic Renaud, Richard Greil, Alejandro Martín García-Sancho, Sebastian Grosicki, Koen van Eygen, Christiane Copie-Bergman, Corinne Haioun, Catherine Thieblemont
Journal: Blood Advances
Blood Adv (2021) 5 (15): 2965–2968.
https://doi.org/10.1182/bloodadvances.2021004766
Published: 2021
Includes: Supplemental data